Pregnancy history and risk of endometrial cancer

Epidemiology

Volumn 22, Issue 5, 2011, Pages 638-645

  Pocobelli, Gaia ^a   Doherty, Jennifer A ^b   Voigt, Lynda F ^a,b   Beresford, Shirley A ^a,b   Hill, Deirdre A ^c   Chen, Chu ^a,b,d   Rossing, Mary Anne ^a,b   Holmes, Rebecca S ^a,b   Noor, Zorawar S ^e   Weissa, Noel S ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; BIRTH; BODY MASS; CANCER RISK; EDUCATION; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; NULLIPARA; PARITY; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR;

ADENOCARCINOMA; AGE FACTORS; AGED; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; PARITY; POPULATION SURVEILLANCE; PREGNANCY; QUESTIONNAIRES; REGISTRIES; REPRODUCTIVE HISTORY; RISK FACTORS; WASHINGTON;

EID: 80051548320     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3182263018     Document Type: Article

References (27)

1. Cook LS, Weiss NS, Doherty JA, Chen C. Endometrial cancer. In: Schottenfeld D, Fraumeni JF Jr., eds. Cancer Epidemiology and Prevention. 3rd ed. New York: Oxford University Press; 2006:1027-1044.
2. Beresford SA, Weiss NS, Voigt LF, McKnight B. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet. 1997;349:458-461. (Pubitemid 27077825)
3. Hill DA, Weiss NS, Beresford SA, et al. Continuous combined hormone replacement therapy and risk of endometrial cancer. Am J Obstet Gynecol. 2000;183:1456-1461. (Pubitemid 32061207)
4. Doherty JA, Cushing-Haugen KL, Saltzman BS, et al. Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer. Am J Obstet Gynecol. 2007;197:e1-e7.
5. Bodelon C, Doherty JA, Chen C, Rossing MA, Weiss NS. Use of nonsteroidal antiinflammatory drugs and risk of endometrial cancer. Am J Epidemiol. 2009;170:1512-1517.
6. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc. 1978;73:40-46.
7. Marchbanks PA, Mcdonald JA, Wilson HG, et al. The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol. 2002;12:213-221. (Pubitemid 34414934)
8. Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:2548-2556. (Pubitemid 351196308)
9. Brinton L, Sakoda L, Lissowska J, et al. Reproductive risk factors for endometrial cancer among Polish women. Br J Cancer. 2007;96:1450-1456. (Pubitemid 46685791)
10. Lambe M, Wuu J, Weiderpass E, Hsieh C. Childbearing at older age and endometrial cancer risk (Sweden). Cancer Causes Control. 1999;10:43-49. (Pubitemid 29134751)
11. Kvåle G, Heuch I, Ursin G. Reproductive factors and risk of cancer of the uterine corpus: a prospective study. Cancer Res. 1988;48:6217-6221. (Pubitemid 18266825)
12. Karageorgi S, Hankinson S, Kraft P, De Vivo I. Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004. Int J Cancer. 2010;126: 208-216.
13. Dossus L, Allen N, Kaaks R, et al. Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2010;127:442-451.
14. Bevier M, Sundquist J, Hemminki K. Does the time interval between first and last birth influence the risk of endometrial and ovarian cancer? Eur J Cancer. 2011;47:586-591.
15. Pfeiffer R, Mitani A, Landgren O, et al. Timing of births and endometrial cancer risk in Swedish women. Cancer Causes Control. 2009;20: 1441-1449.
16. Salazar-Martinez E, Lazcano-Ponce E, Gonzalez Lira-Lira G, Escudero- De los Rios P, Salmeron-Castro J, Hernandez-Avila M. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico. Cancer Res. 1999;59:3658-3662. (Pubitemid 29381869)
17. Brinton L, Berman M, Mortel R, et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol. 1992;167:1317-1325.
18. Shu X, Brinton L, Zheng W, Gao Y, Fan J, Fraumeni JJ. A populationbased case-control study of endometrial cancer in Shanghai, China. Int J Cancer. 1991;49:38-43.
19. Kalandidi A, Tzonou A, Lipworth L, Gamatsi I, Filippa D, Trichopoulos D. A case-control study of endometrial cancer in relation to reproductive, somatometric, and life-style variables. Oncology. 1996;53:354-359. (Pubitemid 26283775)
20. Wernli K, Ray R, Gao D, De Roos A, Checkoway H, Thomas D. Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women. Cancer Causes Control. 2006;17:949-955. (Pubitemid 44078286)
21. Xu W, Xiang Y, Ruan Z, et al. Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case-control study in urban Shanghai. Int J Cancer. 2004;108:613-619. (Pubitemid 38036665)
22. Parazzini F, La Vecchia C, Negri E, Fedele L, Balotta F. Reproductive factors and risk of endometrial cancer. Am J Obstet Gynecol. 1991;164: 522-527.
23. McPherson C, Sellers T, Potter J, Bostick R, Folsom A. Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study. Am J Epidemiol. 1996;143:1195-1202. (Pubitemid 26178732)
24. Parslov M, Lidegaard O, Klintorp S, et al. Risk factors among young women with endometrial cancer: a Danish case-control study. Am J Obstet Gynecol. 2000;182:23-29. (Pubitemid 30074365)
25. Henderson B, Ross R, Pike M, Casagrande J. Endogenous hormones as a major factor in human cancer. Cancer Res. 1982;42:3232-3239. (Pubitemid 12041084)
26. King RJB, Whitehead MI. Estrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria: application to clinical studies of the climacteric syndrome. In: Jasonni VM, Nenci I, Falmigni C, eds. Progress in Cancer Research and Therapy (Volume 25): Steroids and Endometrial Cancer. Vol. 25. New York: Raven Press; 1983:105-115.
27. Tulchinsky D, Hobel C, Yeager E, Marshall J. Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. Am J Obstet Gynecol. 1972;112:1095-1100.